As the field of bioinformatics research continues to grow, more and more novel techniques are proposed to meet new challenges and improvements upon solutions to long-standing problems.
In science, we generate questions and design experiments to test possible answers to those questions. The ideal experiment involves a carefully controlled system where the impact of changes to a single variable may be measured. In practice, achieving full control over a system is difficult because the systems of most interest tend to be immensely complicated. Especially for complex systems, confounding variables-variables whose behavior can be spuriously attributed to the variable we are explicitly testingmay introduce hidden bias (referred to as omitted-variable bias) and therefore undermine an experiment. The degree to which omitted-variable bias is minimized is directly related to the accuracy of information which may be gleaned from an experiment. The MS-omics (proteomics, lipidomics, and metabolomics prosecuted via mass spectrometry) community has been extremely careful to control for confounding variables in sample preparation/processing and mass spectrometry analysis (hereafter called lab protocol). But somewhat surprisingly, this meticulousness has not extended as uniformly to data processing protocols in these same experiments. It seems obvious that data processing can and will influence experimental outcomes, just as changes to lab protocol do, and this influence should be expected to grow as the complexity of algorithms and data sets increases.
Consider two experiments carried out on the same mass spec output files in search of drug biomarkers. In Adam et al. (2002) and Qu et al. (2002) , the same group conducted two analyses of the same data set to predict cancer biomarkers. Despite the fact that the experimental variation was limited to the choice of * to whom correspondence should be addressed post-processing bioinformatics tools (in this case, classification algorithms), the experiments yielded only two mutual m/z features (see Figure 1 ). The diagnostic biomarkers selected as well as the sensitivity and specificity of the diagnostic changed due solely to the data processing protocol details (see Table 1 ). Data processing protocol can and does influence experimental outcomes. In data processing protocol, just as in lab protocol, limiting confounding variables boils down to limiting novel aspects under experiment. We suggest three guidelines to mitigate dataprocessing-related omitted-variable bias in MS-omics.
First, bioinformatics methods must be sufficiently described to permit replication, and parameters must be set to the established community standard independently demonstrated as effective in Table 1 . A comparison of m/z values of biomarkers to diagnose cancer from two papers that used the same data set, with the only variability between them being the choice of bioinformatics tools used to post-process the data.
Study
Features Sensitivity Specificity . Consequently, a paper can meet the HUPO-PSI minimum reporting standards and still be completely unreproducible. Second, new bioinformatic tools or unproven parameter settings ought to be presented and evaluated independently from studies designed for clinical outcomes. It is already accepted that a new lab method deserves its own paper in which there is sufficient room to describe the method in reproducible detail as well as to ascertain its strengths and weaknesses in controlled experiments over a variety of data sets. The same standard ought to apply to bioinformatics methods. All too often, a paper whose focus is answering a chemical, biological, or clinical question is used as a vehicle to present a novel data processing method. Introducing a new variable in order to study another variable should at the least be somewhat disconcerting to any scientist. It is far more clear and appropriate to present novel methods in their own right.
Third-and most importantly-whenever possible, bioinformatics algorithms ought to be implemented following the single responsibility principle (SRP)-each module should have only one responsibility. In other words, algorithms ought to do one thing and do it well. This is not only a good programming philosophy but also a good experimental protocol philosophy that is at the heart of the scientific method-isolate and measure the variable of interest. New data processing methods, when coded modularly, are plug-in compatible with existing pipeline modules. Plug-in compatibility allows for a quick and comprehensive evaluation of new methods to ascertain downstream effects in the MS-omics pipeline. This approach has been implemented in frameworks for MS analysis (see, for example, mzMine 2 Pluskal et al. (2010) and OpenMS Sturm et al. (2008) ), yet new algorithms are consistently presented independently of these frameworks. Not only are these new contributions more difficult to use and evaluate due to their independent packaging, their non-modular interfaces and secondary functionality (visualizations, data import/export, etc.) are usually second rate to the full modular frameworks mentioned above. Packaging an alignment algorithm with yet another 2-D LC-MS display makes about as much sense as bundling a newly invented pipette with a second-rate centrifuge. Modularity not only facilitates the isolation of new variables but also decreases the learning curve by cutting down the need to install new software, learn new interfaces, deal with new file types, and facilitate transfer to the existing workflow. What's more, because of the number of confounding variables and added obfuscation, lack of modularity decreases the ease and transparency of evaluation against other methods, stifling innovation and community progress Smith et al. (2013) .
We suggest that practitioners treat confounding variables in the MS-omics toolkits with as much care as they do with confounding variables in the mass spec experimental protocol. A modular approach to bioinformatic tool development will help minimize omitted-variable bias, make bioinformatic tools interchangeable parts in the data processing pipeline, and facilitate extensive evaluation in controlled conditions before use in clinical application.
KEY POINTS
• Choice of bioinformatic data processing algorithms and parameters affect the outcome of MS-omics experiments.
• Mitigation of confounding variables is just as important for data processing portions of the experiment as they are for lab portions and should be treated with as much care in practice and detail in publication. Each data processing variable necessary to reproduce the results ought to be reported in the article or supplemental information, including software choices and parameter settings.
• Novel algorithmic protocols ought to be introduced in their own dedicated article complete with either open source code or sufficient detail to reproduce the algorithm as well as sufficient evaluation with existing approaches to establish performance and detail shortcomings. It is not appropriate to introduce novel data processing techniques as a part of an experiment's protocol.
